An Insight into Analytical Quality by Design in the Pharmaceutical Industry
Kate Mosford of The Column spoke to Rosario LoBrutto of Teva about the business of analytical QbD, the steps involved in implementing it, and advice to those who want to get started.
Kate Mosford of The Column spoke to Rosario LoBrutto of Teva about the business of analytical QbD, the steps involved in implementing it, and advice to those who want to get started.
Articles in this issue
Watermelon Juice Enhances Athletic Performance More Than Pharmacological Standard
LC–MS–MS Yields Information About Imperial Inca Child Sacrifice Practices
An Insight into Analytical Quality by Design in the Pharmaceutical Industry
The 2013 LCGC Awards: Part 2
Identification and Quantification of Cigarette Smoke Components in Charcoal Filter Facilitated Using Supercritical Fluid Extraction and GC–MS
Pattern Recognition
Helium Supply: The Search For Alternative
Recent Videos
The Current Challenges Mitigating PFAS
The Role of PFAS Impacting Carbon Fluxes
Understanding the Movement of PFAS in the Environment
Where Will Your Data Take You? How Modern Lab Informatics Unlocks Your Potential
The Interactions Between Bacterial Communities and PFAS
The Challenges of Characterizing PFAS in the Environment
Inside the Laboratory: The Mead Group at UNC Wilmington and the North Carolina PFAS Testing Network
Exploring Molecular Dynamics: An Interview with Ezgi Gürler of FeMS
Developing Advanced Fragmentation Schemes: An Interview with Ezgi Gürler of FeMS
Advancing Science Through Diversity: A Conversation with Women in Chromatography, Part 5
Related Content
Regulatory Deadlines and Supply Chain Challenges Take Center Stage in Nitrosamine Discussion
April 10th 2025Article
During an LCGC International peer exchange, Aloka Srinivasan, Mayank Bhanti, and Amber Burch discussed the regulatory deadlines and supply chain challenges that come with nitrosamine analysis.
